Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics. Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that can detect traces of tumor circulating in the blood. The core of Tethis’ innovation lies […]
Trending News
LookDeep Health Announces Advances for Vision AI for Patient Care, Sets Transparency Standard for Smart Hospitals
LookDeep Health today announced it has submitted the most comprehensive paper from any company for peer review detailing its advancements in AI for Smart Hospitals. The manuscript offers a close look at model training, architecture selection, and real-world deployments, reinforcing LookDeep’s leadership in computer vision for hospital environments. By publicly […]
Hippocratic AI Launches AI Agent App Store for Healthcare
Hippocratic AI, the company that pioneered the first healthcare LLM for patient-facing non-diagnostic clinical tasks, today announced the launch of its Healthcare AI Agent App Store. Marking a bold step forward in healthcare innovation, the AI Agent App Store empowers clinicians to design and shape artificial intelligence (AI) agents that […]
Femtech Ultrasound AI company adds cloud-based solution, soniopedia
Sonio, the MedTech company specializing in women’s and children’s health, today announces soniopedia: A New Era in Prenatal Training. soniopedia, which is not a medical device, allows health professionals to have access to a probabilistic artificial intelligence model that has been trained on fetal medicine databases such as Omim, Orphanet […]
Regard Raises $61M to close the Clinical Insights Gap in Healthcare with leading AI solution
Strategic investment from Oak HC/FT and Cedars-Sinai Health Ventures will support the rapid expansion of Regard’s AI-powered clinical insights platform aimed at unlocking the full power of the EHR LOS ANGELES, July 11, 2024 /PRNewswire/ — Regard, the AI-powered clinical insights platform that empowers clinicians to unlock the full potential of patient data, […]
Cognito raises $35 million for Alzheimer’s treatment device, touts benefits compared to drugs
Alzheimer’s disease affects nearly 6 million Americans. It’s the sixth leading cause of death among all adults and the fifth leading cause for those aged 65 or older, and the problem is only getting worse as the country ages: in 2016, 49 million adults living in the United States were […]
PointClickCare Acquires CPSI Subsidiary, American HealthTech
PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the acquisition of American HealthTech, Inc. (AHT), a subsidiary of Computer Programs and Systems, Inc. and a leading provider of electronic health record (EHR) solutions […]
Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing
Oxford Nanopore Technologies plc, a company providing next-generation nanopore-based molecular sensing technology, and Saphetor, a next-generation sequencing data analysis company, today announce a new partnership to support supports comprehensive analysis of nanopore sequencing data and enables comprehensive analysis of nanopore sequencing data. -end of workflow. The collaboration with Saphetor will […]
Verily and OneOncology Announce Collaboration to Advance Cancer Research
Verily, a precision medical technology company of Alphabet, and OneOncology, the national platform for independent oncology practice, have established a strategic partnership that enables more effective clinical trials. As part of the agreement, Verily will integrate the clinical trial management software (CTMS) platform, SignalPath, with all operations in the OneOncology […]
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
ADARx Pharmaceuticals, Inc., a clinical-stage biotech company developing next-generation RNA-based therapies, today announced the successful conclusion of its over-subscribed Series C funding. value of 200 million dollars. The funding was led by Bain Capital Life Science and TCGX and includes new investors Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare […]
